Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events [5/22/18] Läubli et al. J ImmunoTherap Cancer https://t.co/p9WzNDCRPc #ImmunoOnc #IDonc Not according to:
@Cynic2010 Because these drugs are increasing the ability to detect the cancer & remove it by the immune system, there may be increased risk of adverse events if the immune system gets too excited and recognizes other healthy cell parts. https://t.co/h
@drsfrees @DrChoueiri @tompowles1 @Uroweb @florian_krammer Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events [5/22/18] Läubli et al. J ImmunoTherap Cancer h
Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events [5/22/18] Läubli et al. J ImmunoTherap Cancer https://t.co/p9WzNDCRPc #ImmunoOnc #IDonc Not according to: